Certara Products - Simcyp Archives | 第 22 页，共 22 页

Publication

Topotecan is a chemotherapeutic agent of choice for the second-line treatment of recurrent ovarian cancer.…

Certara2011 年 2 月 1 日

Publication

The application of physiologically-based pharmacokinetic (PBPK) modeling is coming of age in drug development and…

Certara2011 年 2 月 1 日

Publication

Generic PBPK models, applicable to a large number of substances, coupled to parameter databases and…

Certara2010 年 12 月 30 日

Publication

The aim of this study was to predict the magnitude of metabolic drug-drug interaction (mDDI)…

Certara2010 年 3 月 18 日

Publication

Allometric scaling is widely used to predict human pharmacokinetic parameters from preclinical species, and many…

Certara2009 年 6 月 1 日

Publication

Nowadays, 50-90% of drugs used in children have never been actually studied in this population. Consequently, either…

Certara2008 年 12 月 1 日

Publication

BACKGROUND: Erlotinib is an orally active antitumor agent. Analyses in vitro using human liver microsomes and…

Certara2008 年 1 月 1 日

Publication

In adapting to the challenge to make more informed selection of compounds for development, the…

Certara2007 年 12 月 1 日

沪ICP备2022021526号

Certara Products – Simcyp